The SRPT chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the SRPT chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.
The SRPT stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.
|View SRPT Detailed Price Forecast - CNN Money||View SRPT Detailed Summary - Google Finance|
|View SRPT Detailed Summary - Yahoo! Finance||View SRPT Stock Research & Analysis - Zacks.com|
|View SRPT Trends & Analysis - Trade-Ideas||View SRPT Major Holders - Barrons|
|View SRPT Call Transcripts - NASDAQ||View SRPT Breaking News & Analysis - Seeking Alpha|
|View SRPT Annual Report - CompanySpotlight.com||View SRPT OTC Short Report - OTCShortReport.com|
|View SRPT Fundamentals - TradeKing||View SRPT SEC Filings - Bar Chart|
|View Historical Prices for SRPT - The WSJ||View Performance/Total Return for SRPT - Morningstar|
|View the Analyst Estimates for SRPT - MarketWatch||View the Earnings History for SRPT - CNBC|
|View the SRPT Earnings - StockMarketWatch||View SRPT Buy or Sell Recommendations - MacroAxis|
|View the SRPT Bullish Patterns - American Bulls||View SRPT Short Pain Metrics - ShortPainBot.com|
|View SRPT Stock Mentions - StockTwits||View SRPT Stock Mentions - PennyStockTweets|
|View SRPT Stock Mentions - Twitter||View SRPT Investment Forum News - Investor Hub|
|View SRPT Stock Mentions - Yahoo! Message Board||View SRPT Stock Mentions - Seeking Alpha|
|View Insider Transactions for SRPT - SECform4.com||View Insider Transactions for SRPT - Insider Cow|
|View SRPT Major Holdings Summary - CNBC||View Insider Disclosure for SRPT - OTC Markets|
|View Insider Transactions for SRPT - Yahoo! Finance||View Institutional Holdings for SRPT - NASDAQ|
|View SRPT Stock Insight & Charts - FinViz.com||View SRPT Investment Charts - StockCharts.com|
|View SRPT Stock Overview & Charts - BarChart||View SRPT User Generated Charts - Trading View|
Biotech Stocks Earnings Lineup for Oct 24: VRTX, ALXN & SRPT
Posted on Tuesday October 23, 2018
Three biotech stocks are scheduled to release their third-quarter results on Oct 24. Let's take a look at how these companies are poised ahead of their earnings release.
Sarepta Therapeutics’ Q3 2018 Earnings: What Can We Expect?
Posted on Tuesday October 23, 2018
Sarepta Therapeutics (SRPT) is expected to report its third quarter of fiscal 2018 earnings on October 24. Analysts expect revenues to increase 72.27% to $79.17 million, from $45.95 million in the third quarter of fiscal 2017. For fiscal 2018 and fiscal 2019, Sarepta Therapeutics is expected to generate revenues of $302.12 million and $429.78 million, respectively. Sarepta Therapeutics is expected to incur selling, general, and administrative expenses of $47.7 million in the third quarter of 2018 compared to $62.41 million in the third quarter of 2017, a decrease of 23.57%.
See what the IHS Markit Score report has to say about Sarepta Therapeutics Inc.
Posted on Saturday October 20, 2018
Short interest is moderately high for SRPT with between 10 and 15% of shares outstanding currently on loan. The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Over the last one-month, outflows of investor capital in ETFs holding SRPT totaled $1.72 billion.
Sarepta Therapeutics to Announce Third Quarter 2018 Financial Results and Recent Corporate Developments on October 24, 2018
Posted on Thursday October 18, 2018
Sarepta Therapeutics, Inc. (SRPT), a leader in precision genetic medicine for rare diseases, will report third quarter 2018 financial results after the Nasdaq Global Market closes on Wednesday, October 24, 2018. Subsequently, at 4:30 p.m. Eastern Time, the Company will host a conference call to discuss its third quarter 2018 financial results and to provide a corporate update. The conference call may be accessed by dialing 844-534-7313 for domestic callers and +1-574-990-1451 for international callers.